NEW YORK (GenomeWeb) – German T-cell research tools firm Lophius Biosciences today announced an exclusive distribution agreement with BL&H for its T-Track CMV kit in South Korea.

Under the terms of the agreement, BL&H will market and sell the test to transplantation centers. The diagnostic assay combines ELISpot assay technology with T-activation technology to measure cytomegalovirus-specific cell mediated immunity in immunocompromised patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.